ASRT Assertio

Watchlist

0.726
-0.042-5.46%

Close Mar 26 16:00 ET

0.760
+0.034+4.68%

Post 19:24 ET

69.53MMarket Cap-3.16P/E (TTM)

About Assertio Company

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Company Profile

SymbolASRT

Company NameAssertio

Listing DateDec 2, 1997

Founded1995

CEOMs. Heather L. Mason

MarketNASDAQ

Employees58

Fiscal Year Ends12-31

Address100 South Saunders Road,Suite 300

CityLake Forest

ProvinceIllinois

CountryUnited States of America

Zip Code60045

Phone1-224-419-7106

Websitehttp://www.assertiotx.com

Company Executives

Name
Position
Salary

Brendan P. O’Grady
Co-Chief Executive Officer
--

Ajay Patel
Senior Vice President, Chief Financial Officer and Chief Accounting Officer
1.06M

Paul Schwichtenberg
Chief Transformation Officer
1.09M

Mary E. Pietryga
Chief Commercial Officer
--

Sam Schlessinger
Senior Vice President and General Counsel
--

Heather L. Mason
Chairman of the Board
353.02K

Mark Reisenauer
Director
--

James L. Tyree
Independent Director
346.89K

Sigurd C. Kirk
Independent Director
--

Sravan K. Emany
Independent Director
223.80K

David Matthew Stark
Independent Director
--

William T. Mckee
Independent Director
356.52K

ASRT Assertio

About Assertio Company

Company Profile

Company Executives

Market Insights